← BackEdwards Lifesciences Corp · Orthopedic, Prosthetic & Surgical Appliances & SuppliesEW
Low riskNext report: In 1 days (est.)
The short versionA high-quality, profitable business with growing sales. Institutions are adding.
Going well
- Sales up 14% in the latest quarter vs a year ago
- Profitable every year for 10 years
- Sales up 12% last year
Money moves
- Insiders sold $53K in the last 30 days, all through pre-planned sales
- Institutions added 4.1% to their holdings in the quarter ending June 2026 (609 bought, 564 sold)
- Held by Ray Dalio (Bridgewater)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$90.57+1.7% that day
- Company value
- $52.2B
- Share price times all shares
- Price vs profit (P/E)
- 52.1x
- You pay about $52 for each $1 of yearly profit
- Price vs sales
- 8.0x
- Company value is 8.0 times a year of sales
- Cash vs value
- 6%
- Cash as a share of company value
- Debt vs value
- 1%
- Debt as a share of company value
From EW's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Jun '26$1.7B+14% vs a year earlier
Sep '23Tap a barJun '26
Last 12 months: $6.5B, up 15% from the 12 months before. Over 5 years, sales grew about 6.7% a year.
Business quality
The checklist Warren Buffett-style investors use. Annual numbers for 2025.- MissReturn on equity 15%+Earns a lot on the money owners have in the business.10.6%
- PassDebt under half of equityNot relying on borrowed money.0.06x equity
- PassNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.17.7%
- PassProfitable every yearSteady profits, not one good year.10 of 10 years
- PassFree cash flow positiveBrings in more cash than it spends to run and grow.$1.3B
- PassShare count not growingNot diluting owners. Falling means buybacks.-6.2% in 3 years
- PassGross margin 40%+Pricing power: sells for well above what it costs to make.78.0%
- Revenue
- $6.1B
- +11.5% vs prior year
- 5-year growth
- +6.7%/yr
- revenue, per year
- Total debt
- $598.3M
- 0.06x equity
- Current ratio
- 3.72x
- short-term assets / bills due
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Jun 30, 2026- Revenue
- $1.7B
- +13.6% YoY
- EPS
- $0.42
- vs $0.56
- Op. margin
- 29.5%
- +2.7 pts
- Gross margin
- 77.5%
- 0.0 pts
- Free cash flow
- $585.0M
- Share count
- -1.8%
- vs a year ago
Insider rating
Last 90 days
48Mixed
- Pre-planned sales of $53K (weaker signal)
50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.
Weekly insider trend13 weeks agoBoughtSoldThis week
Filing buzz
Last 7 days vs normal
0/ 100
- This week
- 0
- Normal week
- 1.9
- vs normal
- 0.0x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
▲Accumulating+4.1%Institutions added 4.1% to their holdings. 609 bought, 564 sold.
Shares held by institutions525.6M
Sep '24Jun '26
Share count growthYearly rate, last 3 years
-1.7%Cash runwayAt last year's cash burn
Cash flow positiveDebt to equityLatest balance sheet: debt compared with what owners have
0.1x · $598.7M debtShares outstandingLatest reported
576MNext reportIn 1 days (est.)Estimated from the same quarter last year
- Results filedJul 23
- Results filedApr 23
- Results filedFeb 10
- Results filedOct 30, 2025
- Results filedJul 24, 2025
Flags and big holders
Offerings 6 months, flags 12 months, holders 90 days
No offerings, red flags or new big holders. Clean record.
Insider trades
Open-market buys and sells, last 90 days Bought$00 insiders
Sold$53K1 insider, 1 pre-planned
| Insider | Trade | Shares | Avg price | Value | Owns after | Date |
|---|
Daniel J. LippisCVP, TAVR | Sell | 619 | $85.65 | $53K | 40K | |
- -1.5% of their holdings
- Pre-planned sale (10b5-1)
- Filed same day
|
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
Latest filings
Straight from SEC EDGAR
SoldDaniel J. LippisCVP, TAVR
619 shares at $85.65 · $53K
- -2% of holdings
- Now owns 40,034 shares
- Pre-planned sale (10b5-1)
- Filed same day
- Also: Option exercise
Shares withheld for taxesAndrew M. DahlSVP, Corporate Controller
253 shares at $84.37 · $21K
- -2% of holdings
- Now owns 14,615 shares
- Filed 1 day after trade
Shares withheld for taxesWayne MarkowitzCVP, JAPAC
923 shares at $85.29 avg ($84.37 to $86.77) · $79K
- -5% of holdings
- Now owns 19,371 shares
- 2 transactions
- Filed same day
SoldDaniel J. LippisCVP, TAVR
619 shares at $87.51 · $54K
- -2% of holdings
- Now owns 40,034 shares
- Pre-planned sale (10b5-1)
- Filed same day
- Also: Option exercise
Shares withheld for taxesDaveen ChopraCVP, TMTT, Surgical & IHFM
398 shares at $86.77 · $35K
- -1% of holdings
- Now owns 43,926 shares
- Filed same day
SoldAndrew M. DahlSVP, Corporate Controller
544 shares at $91.06 · $50K
- -4% of holdings
- Now owns 14,868 shares
- Not a pre-planned sale
- Filed same day